Company intelligence / Profile preview

Daisy Technology

Auckland, Auckland Region, New Zealanddaisy.org ↗

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Daisy Lab has developed yeast strains capable of producing animal-identical dairy proteins such as beta-lactoglobulin and lactoferrin using precision fermentation. The company has achieved multi-liter scale production and received regulatory approval to expand its platform to a 5,000 L fermenter. This enables commercial-scale production of bioidentical whey proteins for use in foods and supplements. No clinical results as the products are not therapeutics but food ingredients.

Therapeutic areas: Other
Modalities: Protein (recombinant protein)Precision fermentation-derived protein
Industry: Non-Drug Biotech

Partnerships

No major pharma or biotech partnerships reported as of June 2025.

Beyond the preview

Go deeper on Daisy Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daisy Technology.

Explore the full profile